North America NASH Biomarker market

united states accounted for the larger market share in 2018 in the north america nash biomarker market, and is expected to reach usd 653.90 million in 2024 from usd 193.70 million in 2018. however, canada is the fastest growing market, which is expected to grow at a cagr of 24.33% during the forecast period 2019 - 2024. pharmaceutical companies and cros segment accounted for the largest market share in 2018, this market is expected to reach usd 337.70 million in 2024 from usd 96.00 million in 2018. this market is projected to grow at a cagr of 22.09% during the forecast period from 2019 - 2024. serum biomarkers segment accounted for the largest market share in 2018, this market is expected to reach usd 318.30 million in 2024 from usd 90.30 million in 2018. this market is projected to grow at a cagr of 21.95% during the forecast period from 2019 - 2024. however, hepatic fibrosis biomarkers segment is the fastest growing market, which is expected to grow at a cagr of 22.27% during the forecast period 2019 - 2024.